Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (NIH Clinical Center Office of Patient Recruitment (OPR) · ccopr@nih.gov · 800-411-1222
Study leads
Laura S Samples, M.D.
Principal Investigator
National Heart, Lung, and Blood Institute (NHLBI)